CSF3 and graft versus host disease: In general, G-CSF/ATG can mitigate GVHD by eliminating alloreactive T cells and facilitating immune tolerance, while HD-PTCy can reduce alloreactive T cell proliferation, impair the function of surviving alloreactive T cells, and lead to preferential recovery of regulatory T cells (33, 34).